A PHASE 2 RANDOMIZED, CONTROLLED, DOUBLE-MASKED, MULTICENTER CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EXPLORATORY EFFICACY OF LUMINATE® (ALG-1001) AS COMPARED TO AVASTIN® AND FOCAL LASER PHOTOCOAGULATION IN THE TREATMENT OF DIABETIC MACULAR EDEMA: